Dr. Rajinder Pal Singh Bajwa, MD

Dr. Bajwa practices at Niagara Falls Memorial Medical Center in Niagara Falls, New York, part of Niagara Falls Memorial Medical Center.

Dr. Bajwa's NPI, 1831419654, was assigned on June 3, 2010. Dr. Bajwa holds New York license 270758.

Dr. Bajwa's primary practice is Niagara Falls Memorial Medical Center, at 621 Tenth Street, Niagara Falls, NY 14302 in Niagara County. The practice phone is (716) 278-4000.

Dr. Bajwa's primary practice is Niagara Falls Memorial Medical Center in Niagara Falls, New York, part of Niagara Falls Memorial Medical Center. Dr. Bajwa is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is Niagara Falls Memorial Medical Center. Dmand AI also links Dr. Bajwa to 2 more hospitals, 2 medical groups and 1 skilled nursing facility, each named with a free account. Dr. Bajwa's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bajwa practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Bajwa's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Bajwa's licenses on file in 2 states: New York and Florida.

CMS data shows 274 Medicare services from Dr. Bajwa across 6 procedure codes in 2024, for 79 Medicare patients. Medicare paid $15,821 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 79 Medicare patients who saw Dr. Bajwa in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 3.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bajwa's median patient age at 69, with 42% women.

In 2024, Dr. Bajwa wrote 551 Medicare Part D claims for 136 patients. 70% of them were for generic drugs. CMS names the drug for 414 of them, across 16 drugs with 11 or more claims each, at $541,443 in total drug cost. In 2023, CMS named 338 claims across 17 drugs.

Dr. Bajwa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 142 procedures of removal of tissue by Dr. Bajwa, more than 89% of the clinicians it reports for that procedure.

CMS Open Payments shows 371 general payments to Dr. Bajwa from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Gilead Sciences, Inc. paid the most, $5,693.